De Maeseneer Daan

Day Two of #BLADDR25 #GlobalForum25 in Portugal 🇵🇹 Kicking off with a presentation from Dr. Eva Comperat of Vienna, Austria🇦🇹 & Paris, France🇫🇷 Session 🔟Years of BLADDR #BladderCancer (Past to Present): The Pathologist Viewpoint @Ric_Campi @achoud72 @daandm @bm_deruiter @mdesantis234 @nachoduranm @fontev1 @PGrivasMDPhD @DrFelixGuerrero @bkonety @Uro_Kris @UroMoschini @PignotG @HenningPlage @tompowles1 @DanieleRaggi83 @b_szabados @BenteThoft @UrsulaVogl @nataliagandur @DrRishabhOnco @mirrorsmed

Arrived in Lisbon for #renalc25 and #bladdr25. Great days ahead! @mirrorsmed

@ First Presidential #esmo2025 !

Which treatment would you offer to Charlize, recently diagnosed with metastatic #BladderCancer? 📌Compare your choice with your peers and check the expert opinions in our updated case-based #CME course “First-line therapy of synchronous and metachronous metastatic UCa”: ppcp.mirrorsmed.org/en/topic/i6xwn… Multidisciplinary expert panel @daandm @ElieRassy @amerseburger @b_szabados @achoud72 @Shaista_Hafeez @cnsternberg @BlancJeremy @mdesantis234 @UrsulaVogl Frederiek D’Hondt, Aristotelis Bamias, Arnoud Templeton, Richard Cathomas, Rob Jones @OncoAlert

Enter TheKiteMag's giveaway to win prizes from Mystic, Lieuwe, Duotone, Slingshot & Levitaz. #Kiteboarding upvir.al/ref/6543d03f7e…

@tomvandenbulcke Zeer sterk #diw vibes met ‘Hoge School’ bijdrage… kan vlotter/moderner.

Kijken? 👉 bit.ly/GNTCLU-AVS 👀

The programme for #BLADDR23 in Malaga, Spain is online! 
 Looking forward to seeing the faculty, community and partners there from 1– 2 December 2023! 

Don’t forget to get your early bird tickets before 22 October 2023. 
 Want to know more? See the programme here prosca-bladdr.org/programme-2023… @UrsulaVogl @PaulSargos @DrFelixGuerrero @xmaldona @IraniJacques @b_szabados @daandm @achoud72 @fontev1 @LAUrology_NL @Achard_Verane @nachoduranm @evacomperat @bkonety @E_Laukhtina @UroMoschini @OncoAlert

College graduation speeches are often evergreen. They can be given at any time, similar from decade to decade. Which is why Illinois Governor J. B. Pritzker’s “How To Spot An Idiot” at Northwestern’s graduation is so genius. It is the speech for TODAY

📣We just published final results of our CHEERS trial @JAMAOnc investigating the combination of subtotal subablative SBRT ☢️ with anti-PD-(L)1 monotherapy 💉 in pts with advanced solid tumors ja.ma/3pBquxM

📣New Publication Alert: Radiotherapy use in muscle-invasive bladder cancer by @FlorVerghote ❗️Very pleased & proud to be part of this MDT working on the optimization of care for bladder cancer patients @fontev1 @CharlesPraet @uzgent @ugent_fge dovepress.com/radiotherapy-u…

Op 11 maart schreef @jdceulaer over het 'echte' verhaal van de pandemie. demorgen.be/nieuws/het-ech… Vandaag is mijn Recht van Antwoord verschenen, enkel in de gedrukte versie van @demorgen. Dit bleek onmogelijk zonder genereuze juridische hulp. Recht is er niet voor iedereen. 1/3

@OCorbhuiPol @Millar_Colin Regular season points count only for half during play-offs. Winner of PO takes championship.

@Millar_Colin All the teams have won 25, drawn 8 and lost 7 in the league table.. so how have two teams fin level on points and R.A. finished a point ahead of them, their G.D. is not even the best of the three teams????

An all-time great football moment. Toby Alderweireld joined hometown club Royal Antwerp last summer, as he always promised he would. Tonight, he has won them their first league title since 1957 with this incredible strike vs Genk in the 94th minute!

I always use this slide to explain why we can propose screening in PCa.

Elsevier is losing editors

Ready for day 2 💪!

@tomvandenbulcke Dikke proficiat en zeer goed werk! Hopelijk geen Chinese ambities … Wanneer kaagent@mastodon ?

Dag op dag 1 jaar aan de slag. Geen aprilvis, wel serious business. 1 jaar, wat meer grijs haar, want met Buffalo’s ben je nooit klaar. Merci voor de afgelopen 365 dagen. Ik ga ze me nooit beklagen 🙏💙

@ChrisSweens1 @brookmans76 @DrSpratticus Thanks Chris 🙏 so at present (if you could) would you use ARI + PARPi in all comers? I worry about toxicity, adherence and Magnitude of benefit @Ecastromarcos @EfstathiouEleni @quimmateo @AdamSharpMedOnc @AzadOncology @neerajaiims

AstraZeneca $AZN and Merck $MRK present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium mOS 42.1 vs 34.7mo OS HR 0.81 - 95%CI 0.67-1.00; p=0.0544 #sadthrombone businesswire.com/news/home/2023…

Disappointing end to UK space mission as satellites fail to reach orbit | Space | The Guardian. @NoContextBrits theguardian.com/science/2023/j…

My crankometer just broke ...